Vivos Therapeutics, Inc. VVOS 深 滬
已收盤 06-05 16:00:00 美东时间
0.8645
+0.172
+24.84%
華盛通- 最 高1.36
- 今 開0.7251
- 成交量 7022.54万股
- 最 低 0.7015
- 昨 收 0.6925
- 總市值 1.20万
- 52周最高 7.95
- 市盈率 靜 --
- 換手率 505414.97%
- 52周最低 0.545
- 委 比 18.14%
- 總股本 1.39万
- 歷史最高 360.25
- 量 比 774.91
- 振 幅 95.09%
- 歷史最低 0.545
- 每 手 1
- 風險率 1.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 绩后暴跌，博通仍获11家大行上调目标价；CrowdStrike获21家大行集体上调目标价；Netskope、Veeva Systems惨遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Vivos Therapeutics"买入"评级，目标价从3美元升至3.1美元；富国银行：维持Veeva Systems"超配"评级，目标价从317美元升至320美元
06-05 11:33
CrowdStrike To Surge Nearly 25%? Here Are 10 Notable Analyst Calls From Thursday
Top Wall Street analysts updated ratings on CRWD, OLLI, XPO, SHAK, UNH, PVH, VVOS, and SYRE. See analyst ratings page for full details.
06-04 20:40
Ascendiant Capital Maintains Buy on Vivos Therapeutics, Raises Price Target to $3.1
Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics (NASDAQ:VVOS) with a Buy and raises the price target from $3 to $3.1.
06-04 17:52
Vivos Therapeutics Balances Rapid Growth With Cash Strain
Vivos Therapeutics, Inc. (($VVOS)) has held its Q1 earnings call. Read on for t...
05-23 08:13
Vivos Therapeutics Q1 EPS $(0.52) Misses $(0.45) Estimate, Sales $5.141M Beat $4.225M Estimate
Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.45) by 15.56 percent. This is a 15.56 percent decrease over losses of $(0.45) per share
05-21 04:18
美股大行评级 | 巴克莱大幅上调希捷科技、西部数据目标价！联合健康、霍顿房屋、盈透证券、奎斯特诊疗等获多家机构上调目标价
今日重点评级关注：Piper Sandler：维持MeiraGTx Holdings"超配"评级，目标价从26美元升至30美元；康托·菲茨杰拉德：维持MKS Inc."超配"评级，目标价从300美元升至400美元
04-23 12:35
Qorvo To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Wall Street analysts changed their outlook on top names. For all rating changes, see analyst ratings page. Vivos, Airbnb, Gitlab, Frontline, Qorvo, Valmont, Chubb, and UnitedHealth saw price target changes and upgrades/downgrades.
04-22 20:48
美股大行评级 | 美银证券上调闪迪目标价从900美元升至1080美元；纽约梅隆银行、Onto Innovation、安博、美国合众银行等获多家大行上调目标价
今日重点评级关注：Guggenheim：维持AtaiBeckley Inc."买入"评级，目标价从11美元升至16美元；RBC Capital：维持MeiraGTx Holdings"跑赢大市"评级，目标价从16美元升至24美元
04-20 11:33
Vivos Therapeutics shares are trading lower after the company reported worse-than-expected Q4 financial results.
Vivos Therapeutics shares are trading lower after the company reported worse-th...
04-16 23:44
Vivos Therapeutics Q4 EPS $(0.58) Misses $(0.48) Estimate, Sales $3.824M Miss $6.447M Estimate
Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.48) by 20.83 percent. This is a 107.14 percent decrease over losses of $(0.28) per share
04-16 04:25
